Analysis

Royalty Pharma Plc (RPD) Stock Analysis

Royalty Pharma Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to RPD.

websiteRPD/analysis/RPD

Royalty Pharma Plc

Royalty Pharma Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to RPD.

Stock profile

Ticker

RPD

Asset type

Stock

Market cap

$31.60B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

EUR

Ticker listings

Royalty Pharma Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • RPRX primary listing
  • RPD primary listing
  • A2P62D
  • RPRXN

Latest Royalty Pharma Plc news

Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

Royalty Pharma to present at upcoming investor conferences

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the m...

Royalty Pharma reports first quarter 2026 results

Portfolio Receipts growth of 10% to $925 million; Royalty Receipts growth of 13%Net cash provided by operating activities of $718 millionRaised full year 2026 guidance: Portfoli...

Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the launch of the Royalty Pharma Translational Prize, which recognizes exceptional...

Royalty Pharma Declares Second Quarter 2026 Dividend

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2026 of...

Research sections

Valuation

Review valuation context for Royalty Pharma Plc.

Future growth

Review future growth context for Royalty Pharma Plc.

Past performance

Review past performance context for Royalty Pharma Plc.

Financial health

Review financial health context for Royalty Pharma Plc.

Dividend

Review dividend context for Royalty Pharma Plc.

Management

Review management context for Royalty Pharma Plc.

Ownership

Review ownership context for Royalty Pharma Plc.

Other information

Review other information context for Royalty Pharma Plc.

Community

Review community context for Royalty Pharma Plc.